Decreased mtDNA, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase γ
Open Access
- 1 April 2007
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 87 (4) , 326-335
- https://doi.org/10.1038/labinvest.3700523
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Mutant POLG2 Disrupts DNA Polymerase γ Subunits and Causes Progressive External OphthalmoplegiaAmerican Journal of Human Genetics, 2006
- Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol γ hypothesisAIDS, 2006
- A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary MedicineAnnual Review of Genetics, 2005
- c-FLIP inhibits chemotherapy-induced colorectal cancer cell deathOncogene, 2005
- Mitochondrial DNA mutations activate programmed cell survival in the mouse heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Parkinsonism, premature menopause, and mitochondrial DNA polymerase γ mutations: clinical and molecular genetic studyThe Lancet, 2004
- Mitochondrial oxidative stress in human hepatoma cells exposed to stavudineToxicology and Applied Pharmacology, 2004
- Structure-function defects of human mitochondrial DNA polymerase in autosomal dominant progressive external ophthalmoplegiaNature Structural & Molecular Biology, 2004
- DNA Polymerase γ, The Mitochondrial ReplicaseAnnual Review of Biochemistry, 2004
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990